Anemia, a common hematological disorder, presents unique diagnostic challenges due to its multifaceted etiology. Understanding these complexities is crucial for healthcare professionals in ensuring effective patient management.
Anemia can be classified according to the size of red blood cells (microcytic, normocytic, or macrocytic) or based on the underlying cause (iron deficiency, vitamin B12/folate deficiency, hemolytic, or anemia of chronic disease). This initial classification can guide further diagnostic investigations.
Complete blood count (CBC) and reticulocyte count are the initial investigations for suspected anemia. Further, serum iron studies, vitamin B12 and folate levels, haptoglobin, lactate dehydrogenase (LDH), and peripheral blood smear can provide insights into the underlying etiology. In some cases, bone marrow examination may be warranted.
Interpretation of laboratory results should be done in a systematic manner. Microcytic anemia often suggests iron deficiency or thalassemia, while macrocytic anemia may indicate vitamin B12 or folate deficiency, or myelodysplastic syndrome. Normocytic anemia can be due to anemia of chronic disease, acute blood loss, or hemolysis. Hemolytic anemia can be diagnosed by increased reticulocyte count, LDH, and decreased haptoglobin.
While laboratory investigations are crucial, they should be interpreted in the context of the patient's clinical presentation and history. For instance, dietary history, medication use, family history, and associated symptoms can provide valuable clues to the underlying cause of anemia.
In conclusion, the diagnosis of anemia requires a comprehensive approach that includes etiological classification, appropriate laboratory investigations, and careful interpretation of results in the context of the patient's clinical picture. This approach will enable healthcare professionals to accurately diagnose and manage this common but complex disorder.
1.
High Response Rate in Heavily Treated Multiple Myeloma With Novel Drug Combination
2.
Measurable Residual Disease Predicts Real-World AML Relapse
3.
Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects
4.
Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.
5.
Admissions, medical schools, costs, and eligibility requirements information for FNB Head and Neck Oncology.
1.
Modern Developments in Oncology for Specialists
2.
Case-Based Learning: Reasoning Through New Functional Changes During Long-Term Cancer Survivorship
3.
The Latest Advances in Glioblastoma Treatment and Prevention
4.
How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement?
5.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
2.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
4.
Understanding Iron Deficiency and Its Common Symptoms
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation